Long-Term Use of Tedizolid in Osteoarticular Infections: Benefits among Oxazolidinone Drugs.
Eva BenaventLaura MorataFrancesc Escrihuela-VidalEsteban Alberto ReynagaLaura SoldevilaLaia AlbiachMaria Luisa Pedro-BotetAriadna PadullésAlex SorianoOscar MurilloPublished in: Antibiotics (Basel, Switzerland) (2021)
Long-term use of tedizolid was effective, showing a better safety profile with less myelotoxicity and lower drug-drug interaction than linezolid. Confirmation of these advantages could make tedizolid the oxazolidinone of choice for most of osteoarticular infections.